Locus Biosciences
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial) (NCT05488340) | Locus Biosciences | 2022-07-13 |
| Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli (NCT04191148) | Locus Biosciences | 2019-12-30 |
Track Locus Biosciences automatically
Every clearance here is in the API, with alerts when new ones post.